STOCK TITAN

CBIH Welcomes Charles Tamburello to Its Board, Strengthening M&A Strategy

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags

Cannabis Bioscience International Holdings (CBIH) has appointed Charles Tamburello to its board of directors. With nearly three decades of experience in public markets, Tamburello brings extensive M&A expertise and strategic insights to CBIH. As owner-operator of Global Discovery Group, he has helped hundreds of public and private companies since 1995. His appointment aims to strengthen CBIH's M&A strategy, enhance capital acquisition capabilities, and drive sustainable growth. The company expects his industry connections and expertise to facilitate identifying acquisition targets and maximizing deal success.

Cannabis Bioscience International Holdings (CBIH) ha nominato Charles Tamburello nel suo consiglio di amministrazione. Con quasi tre decenni di esperienza nei mercati pubblici, Tamburello porta con sé un'ampia esperienza in fusioni e acquisizioni, oltre a intuizioni strategiche per CBIH. In qualità di proprietario e operatore del Global Discovery Group, ha assistito centinaia di aziende pubbliche e private dal 1995. La sua nomina mira a rafforzare la strategia di M&A di CBIH, migliorare le capacità di acquisizione di capitale e promuovere una crescita sostenibile. L'azienda si aspetta che le sue connessioni nel settore e la sua expertise facilitino l'individuazione di obiettivi di acquisizione e massimizzino il successo delle operazioni.

Cannabis Bioscience International Holdings (CBIH) ha nombrado a Charles Tamburello en su junta directiva. Con casi tres décadas de experiencia en mercados públicos, Tamburello aporta una vasta experiencia en fusiones y adquisiciones, así como perspectivas estratégicas a CBIH. Como propietario y operador del Global Discovery Group, ha ayudado a cientos de empresas públicas y privadas desde 1995. Su nombramiento busca fortalecer la estrategia de M&A de CBIH, mejorar las capacidades de adquisición de capital y fomentar un crecimiento sostenible. La empresa espera que sus conexiones e experticia en la industria faciliten la identificación de objetivos de adquisición y maximicen el éxito de las transacciones.

대마 바이오사이언스 인터내셔널 홀딩스 (CBIH)는 찰스 탐부렐로를 이사회에 임명했습니다. 공공 시장에서 거의 30년의 경험을 가진 탐부렐로는 CBIH에 폭넓은 M&A 전문성과 전략적 통찰력을 제공합니다. 글로벌 디스커버리 그룹의 소유자이자 운영자로서, 그는 1995년부터 수백 개의 상장 및 비상장 기업을 도와왔습니다. 그의 임명은 CBIH의 M&A 전략을 강화하고 자본 조달 능력을 향상시키며 지속 가능한 성장을 추진하는 것을 목표로 하고 있습니다. 회사는 그의 산업 연결망과 전문성이 인수 대상으로 식별하고 거래 성공을 극대화하는 데 도움을 줄 것으로 기대하고 있습니다.

Cannabis Bioscience International Holdings (CBIH) a nommé Charles Tamburello à son conseil d'administration. Fort de près de trois décennies d'expérience sur les marchés publics, Tamburello apporte une vaste expertise en M&A et des insights stratégiques à CBIH. En tant que propriétaire et opérateur de Global Discovery Group, il a aidé des centaines d'entreprises publiques et privées depuis 1995. Sa nomination vise à renforcer la stratégie M&A de CBIH, à améliorer les capacités d'acquisition de capitaux et à favoriser une croissance durable. L'entreprise s'attend à ce que ses connexions dans l'industrie et son expertise facilitent l'identification des cibles d'acquisition et maximisent le succès des transactions.

Cannabis Bioscience International Holdings (CBIH) hat Charles Tamburello in seinen Vorstand berufen. Mit fast drei Jahrzehnten Erfahrung an den öffentlichen Märkten bringt Tamburello umfassende M&A-Expertise und strategische Einblicke in CBIH ein. Als Eigentümer und Betreiber von Global Discovery Group hat er seit 1995 Hunderten von öffentlichen und privaten Unternehmen geholfen. Seine Ernennung zielt darauf ab, die M&A-Strategie von CBIH zu stärken, die Fähigkeiten zur Kapitalbeschaffung zu verbessern und nachhaltiges Wachstum voranzutreiben. Das Unternehmen erwartet, dass seine Branchenverbindungen und Expertise dabei helfen, Übernahmeziele zu identifizieren und den Erfolg von Geschäften zu maximieren.

Positive
  • Addition of board member with 30 years of M&A experience
  • Enhanced access to potential acquisition targets through industry connections
  • Improved capital acquisition capabilities through new expertise
Negative
  • None.

Houston, Texas--(Newsfile Corp. - November 4, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is thrilled to announce the appointment of Mr. Charles Tamburello as a new member of the board of directors. His extensive experience in the public markets, which spans nearly three decades, will play a crucial role in driving the company's mergers and acquisitions (M&A) strategy forward.

Mr. Tamburello has been instrumental in the success of hundreds of public and private companies since 1995, leveraging his deep industry knowledge and valuable connections to facilitate growth and expansion. His track record of orchestrating successful M&A transactions aligns perfectly with CBIH's strategic goals as we look to enhance our capabilities and reach. He is the owner operator of Global Discovery Group, a dynamic platform designed to facilitate engagement between public companies and the investment community, which offers a highly effective and time-efficient way for companies to showcase their latest developments, new products, services, and significant announcements.

"Recognizing the challenges ahead as we strive to reach our ambitious benchmarks, we are committed to bringing on top-tier talent and strategic guidance. Mr. Tamburello exemplifies this commitment," said John Jones, CBIH Treasurer and Director. "His extensive experience in capital acquisition and expertise in navigating complex industries will provide our shareholders with confidence that we are positioned for sustainable growth and value creation."

Charles Tamburello expressed his enthusiasm about joining CBIH, stating, "I'm excited to be a part of the vision of Cannabis Bioscience International and the journey of helping everyday people throughout the world, conquer debilitating ailments and improve their lives."

Mr. Tamburello's appointment to the CBIH board significantly strengthens the company's potential for successful mergers and acquisitions (M&A). His extensive background in executing M&A transactions across diverse sectors equips CBIH with the strategic insights and negotiation skills necessary to identify high-value acquisition targets and maximize deal success. Tamburello's deep industry connections and leadership of The Emerging Growth Conference provide CBIH with enhanced access to potential partners and acquisition opportunities, increasing the likelihood of securing advantageous deals that align with CBIH's growth objectives.

Furthermore, his expertise in capital raising allows CBIH to pursue acquisitions more aggressively, ensuring the company has the necessary resources to act swiftly on opportunities and expand its portfolio. This combination of M&A experience, industry influence, and capital acquisition skills provides CBIH with a competitive edge, enabling the company to grow strategically through targeted acquisitions that bolster its market position and drive long-term shareholder value.

This powerful combination of skills and connections positions CBIH to seize high-value opportunities and strategically expand our portfolio, strengthening our market position and delivering sustained value for shareholders. With Mr. Tamburello's leadership, we are more confident than ever in our path to becoming an industry leader and achieving long-term, transformative growth.

FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements. The words "believe," "expect," "should," "intend," "estimate," "projects," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based upon the Company's current expectations and are subject to a number of risks, uncertainties, and assumptions. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are risks that are detailed in the Company's filings, which are on file at www.OTCmarkets.com.

For more information contact us at:
(214) 733-0868
ir@cbih.net
Dante Picazo
CEO - CBIH
Website: www.cbih.net
X: www.twitter.com/cbihstock
Instagram: www.instagram.com/CBIHSTOCK

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/228741

FAQ

Who is the new board member appointed to Cannabis Bioscience International Holdings (CBIH) in November 2024?

Charles Tamburello was appointed to CBIH's board of directors in November 2024.

What is Charles Tamburello's role at Global Discovery Group?

Charles Tamburello is the owner-operator of Global Discovery Group, a platform that connects public companies with the investment community.

How will Charles Tamburello's appointment benefit CBIH's M&A strategy?

Tamburello's extensive M&A experience, industry connections, and capital acquisition expertise will help CBIH identify acquisition targets and maximize deal success.

CANNABIS BIOSCI INTL HLDG

OTC:CBIH

CBIH Rankings

CBIH Latest News

CBIH Stock Data

7.30M
4.79B
54.67%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Houston